Plasma Perfluoroalkyl Substances Research Articles

Contaminant levels in the world’s northernmost harbor seals (Phoca vitulina)

The world’s northernmost harbor seal (Phoca vitulina) population, which inhabits Svalbard, Norway, constitutes a genetically distinct population. The present study reports concentrations of 14 PCBs, 5 chlordanes, p,p′-DDT, p,p′-DDE, hexachlorobenzene (HCB), mirex, and, α-, β-and γ-hexachlorocyclohexane (HCH) in blubber, and pentachlorophenol, 4-OH-heptachlorostyrene, 10 OH-PCBs and 14 perfluoroalkyl substances in plasma of live-captured harbor seals from this population (4 males, 4 females, 4 juveniles), sampled in 2009–2010. Concentrations of PCB 153, p,p′-DDE, oxychlordane, α-HCH and mirex and perfluoroalkyl sulfonates in Svalbard harbor seals were considerably lower than harbor seal from more southerly populations, while concentrations of HCB, OH-PCBs and perfluoroalkyl carboxylates were similar for harbor seals from Svalbard and southern areas. Concentrations of PCBs and pesticides in the Svalbard harbor seals were 60–90% lower than levels determined a decade ago in this same population. Current concentrations of legacy POPs are not considered a health risk to the harbor seals from Svalbard.

PFAS concentrations in plasma samples from Danish school children and their mothers

Perfluoroalkyl substances (PFASs) are accumulating in our environment and human exposure to these potentially harmful chemicals are of growing concern. In the present study, 116 children aged 6–11 and 143 mothers in two locations in Denmark donated blood samples as a supplement to their participation in the large European human biomonitoring project, DEMOCOPHES (Demonstration of a study to COordinate and Perform Human Biomonitoring on a European Scale). The blood samples were analyzed by LC-MS/MS for the concentration of six PFASs: PFOA, PFHxS, PFNA, PFDA, br-PFOS and n-PFOS. All measured compounds were above the detection limit in both mothers and children except for PFHxS in one child. There was a significant correlation between the levels in children and their mothers, indicating a family-related exposure pattern. However, we also found that the levels of PFOA, PFNA, PFDA, br-PFOS and total-PFOS were significantly higher in children compared to their mothers. This may be due to higher exposure in children through for example dust and soil, and due to the fact that children are smaller in body size and blood volume and hence have a lower storage capacity. Furthermore, we found an association between plasma levels and the age of the mothers and higher levels of plasma PFASs in mothers with low parity. There were no associations between PFAS concentrations and residential area, dietary habits of the participants or with respect to the birth order of the children. The levels are comparable to concentrations found in other Western countries.

Perfluoroalkyl Substances During Pregnancy and Validated Preeclampsia Among Nulliparous Women in the Norwegian Mother and Child Cohort Study

Perfluoroalkyl substances (PFAS) are persistent and ubiquitous environmental contaminants, and human exposure to these substances may be related to preeclampsia, a common pregnancy complication. Previous studies have found serum concentrations of PFAS to be positively associated with pregnancy-induced hypertension and preeclampsia in a population with high levels of exposure to perfluorooctanoate. Whether this association exists among pregnant women with background levels of PFAS exposure is unknown. Using data from the Norwegian Mother and Child Cohort Study conducted by the Norwegian Institute of Public Health, we carried out a study of nulliparous pregnant women enrolled in 2003-2007 (466 cases, 510 noncases) to estimate associations between PFAS concentrations and an independently validated diagnosis of preeclampsia. We measured levels of 9 PFAS in maternal plasma extracted midpregnancy; statistical analyses were restricted to 7 PFAS that were quantifiable in more than 50% of samples. In proportional hazards models adjusted for maternal age, prepregnancy body mass index (weight (kg)/height (m)(2)), educational level, and smoking status, we observed no strongly positive associations between PFAS levels and preeclampsia. We found an inverse association between preeclampsia and the highest quartile of perfluoroundecanoic acid concentration relative to the lowest quartile (hazard ratio = 0.55, 95% confidence interval: 0.38, 0.81). Overall, our findings do not support an increased risk of preeclampsia among nulliparous Norwegian women with background levels of PFAS exposure.